Monthly Wonder Jab Could Cure Millions of Dementia Patients

by Bidita Debnath on December 8, 2013 at 11:33 PM
 Monthly Wonder Jab Could Cure Millions of Dementia Patients

To slow down Alzheimer's relentless attack on the brain, scientists have developed a drug, which will be available in 5 years.

Tests have shown that solanezumab delays the pace of decline by more than a third in those with a mild form of the disease, the Daily Express reported.


Researchers also believe that the treatment could one day be used like statins, with a single jab given to patients before they start showing symptoms of the disease.

Dr Eric Karran, director of research at Alzheimer's UK, has said they were "full of hope" that the drug, which could help "unlock" the secrets of the disease, will be made available to people before the end of the decade.

He said in a conference that if solanezumab is shown to work in mild Alzheimer's disease then the pathway would be to take that earlier.

The drug works by targeting a toxic protein in the brain called beta amyloid, which can build up for a decade before any outward signs of dementia such as memory loss.

Karran said that if its combined with a battery of early detection tests involving scans and memory, treatments could one day lead to "biomarker" tests to accurately spot those at risk before the disease strikes.

People aged between the age of 55 to 90 are being recruited for a study in the US, to examine the drug's effects in people with mild Alzheimer's.

Source: ANI
Font : A-A+



Recommended Readings

Latest Research News

AI Shows Promise in Identifying ADHD
The AI method shows promise in identifying imaging biomarkers for diagnosing ADHD.
Life Expectancy Gap for Autistic Individuals Revealed
Diagnosed autistic individuals showed increased premature mortality in the UK, highlighting urgent needs to address associated inequalities.
Exploring How Hearing Impairment Shapes Dementia Risk
Study reveals a correlation between hearing impairment and distinct brain region variances, contributing to dementia.
Coffee and its Role in Neurodegenerative Disorders
Financial impact of caring for individuals with neurodegenerative disorders reaches hundreds of billions annually in the United States.
Healthcare Industry Struggles With Tech Skills Shortage
Experts emphasize that addressing the skills gap demands immediate attention and innovative solutions, including education, re-training, and significant time investment.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Monthly Wonder Jab Could Cure Millions of Dementia Patients Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests